文献速递肺栓塞与肺血管病

终末期肾病患者中动静脉内瘘与移植物相关肺动脉高压的患病率及影响:系统综述与Meta分析

Prevalence and Impact of Pulmonary Hypertension Associated with Arteriovenous Fistulas and Grafts in End-Stage Renal Disease: A Systematic Review and Meta-Analysis
RSS 订阅 · PubMed 高证据 · 肺动脉高压 · 2026-07-24

该系统综述与Meta分析检索截至2024年12月31日的观察性研究,纳入11项研究共1299例透析患者,其中10项研究1224例患者进入定量合并分析。合并分析显示动静脉内瘘或移植物使用与肺动脉高压存在统计学显著关联(OR 2.06,95%CI 1.69-2.52),异质性低(I²=0%),但留一法分析在移除单一最具影响力研究后关联失去统计学显著性。作者认为该关联为可能性而非因果效应,需谨慎解读。

要点

  • 动静脉内瘘或移植物使用与肺动脉高压合并OR为2.06(95%CI 1.69-2.52),异质性I²=0%。
  • 留一法分析移除单一最具影响力研究后,该关联失去统计学显著性。
  • 五项研究报告连续肺动脉压力,内瘘或移植物组方向性更高,但因异质性极高(I²=99.4%)未行合并。

核心结论

  • 在观察性数据的合成中,动静脉内瘘或移植物使用与非内瘘或移植物通路相比,与肺动脉高压的比值更高相关。
  • 由于所有纳入研究均为观察性且合并估计对个别有影响力的研究敏感,这些发现提示可能的相关性而非因果效应,应谨慎解读。
  • 这些发现支持开展前瞻性血流动力学研究的理由,并支持在高风险透析患者中评估而非假定肺动脉高压监测和个体化通路策略的获益。

研究设计与样本

  • 系统检索PubMed、Embase、Scopus和Web of Science截至2024年12月31日发表的研究,无语言或日期限制。
  • 纳入标准为年龄≥18岁的透析终末期肾病患者,比较动静脉内瘘或移植物通路与非内瘘或移植物对照(如隧道式透析导管或腹膜透析),并报告肺动脉高压患病率或平均肺动脉压力。
  • 采用纽卡斯尔-渥太华量表评估研究质量并评价偏倚风险。
  • 采用随机效应Meta分析计算肺动脉高压患病率的合并比值比(OR),通过I²和Cochran Q评估异质性,并进行敏感性分析和发表偏倚检验(Egger法和Begg法)。
  • 共纳入11项观察性研究(1299例透析患者),排除一项对照臂零事件的研究后,10项研究(1224例患者)进入定量Meta分析。

主要发现

  • 大多数研究样本量小、以横断面为主、方法学质量中等。
  • 合并分析显示动静脉内瘘或移植物使用与肺动脉高压存在统计学显著关联(OR 2.06,95%CI 1.69-2.52),统计异质性低(I²=0%)。
  • 该估计对个别研究敏感:留一法分析中移除单一最具影响力研究后,关联失去统计学显著性。
  • 未检测到发表偏倚的统计学证据。
  • 五项研究报告连续肺动脉压力,内瘘或移植物组方向性更高,但因异质性极高(I²=99.4%)未行合并。

临床怎么用

  • 作者认为这些发现提示可能的相关性而非因果效应,应谨慎解读。
  • 作者认为这些发现支持开展前瞻性血流动力学研究的理由。
  • 作者认为这些发现支持在高风险透析患者中评估而非假定肺动脉高压监测和个体化通路策略的获益。

局限性

  • 大多数研究样本量小、以横断面为主、方法学质量中等。
  • 该估计对个别研究敏感:留一法分析中移除单一最具影响力研究后,关联失去统计学显著性,提示合并结果部分由少数研究驱动而非均匀稳健。
  • 五项研究报告连续肺动脉压力,内瘘或移植物组方向性更高,但因异质性极高(I²=99.4%)未行合并。
  • 所有纳入研究均为观察性,合并估计对个别有影响力的研究敏感,这些发现提示可能的相关性而非因果效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adv Respir Med. 2026 Jul 6;94(4):46. doi: 10.3390/arm94040046. ABSTRACT BACKGROUND/OBJECTIVES: Pulmonary hypertension (PH) is an increasingly recognized complication in patients with end-stage renal disease (ESRD) undergoing hemodialysis, particularly those utilizing arteriovenous fistulas (AVF) or grafts (AVG) for vascular access. The prevalence and clinical impact of PH in this population remain unclear due to methodological heterogeneity and variable diagnostic criteria. This systematic review and meta-analysis aimed to quantify the association between AVF/AVG use and PH prevalence in ESRD patients and to explore sources of heterogeneity. METHODS: A systematic search of PubMed, Embase, Scopus, and Web of Science was conducted for studies published through 31 December 2024, without language or date restrictions. Eligible studies included adults (≥18 years) with ESRD on dialysis, comparing those with AVF/AVG access to non-AVF/AVG controls (e.g., tunneled dialysis catheters or peritoneal dialysis), and reporting PH prevalence or mean pulmonary artery pressures. Study quality was assessed using the Newcastle-Ottawa Scale, and risk of bias was evaluated. A random-effects meta-analysis calculated pooled odds ratios (OR) for PH prevalence, with heterogeneity assessed by I 2 and Cochran's Q. Sensitivity analyses and tests for publication bias (Egger's and Begg's) were performed. Secondary analysis compared pooled mean pulmonary artery pressures between groups. RESULTS: Eleven observational studies (1299 dialysis patients) met the inclusion criteria; ten studies (1224 patients) contributed to the quantitative meta-analysis after exclusion of one study with a zero-event control arm. Most studies were small, predominantly cross-sectional, and of moderate methodological quality. The pooled analysis showed a statistically significant association between AVF/AVG use and PH (OR 2.06, 95% CI: 1.69-2.52), with low statistical heterogeneity (I 2 = 0%). This estimate was sensitive to individual studies: in leave-one-out analysis the association lost statistical significance when the single most influential study was removed indicating that the pooled result is driven in part by a small number of studies rather than being uniformly robust. No statistical evidence of publication bias was detected. Five studies reported continuous pulmonary artery pressures, which were directionally higher in AVF/AVG patients but were not pooled because of extreme heterogeneity (I 2 = 99.4%). Conclusions In this synthesis of observational data, AVF/AVG use was associated with higher odds of pulmonary hypertension than non-AVF/AVG access. Because all included studies were observational and the pooled estimate is sensitive to individual influential studies, these findings indicate a possible association rather than a causal effect and should be interpreted with caution. They support the rationale for prospective hemodynamic studies and for evaluating-rather than presuming the benefit of-PH monitoring and individualized access strategies in higher-risk dialysis patients.

来源:PubMed 高证据 · 肺动脉高压,查看原文。版权归原作者所有。

引用

  1. PubMed 高证据 · 肺动脉高压:Prevalence and Impact of Pulmonary Hypertension Associated with Arteriovenous Fistulas and Grafts in End-Stage Renal Disease: A Systematic Review and Meta-Analysis

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。